CHI3L1 promotes lung cancer progression by inhibiting CTL activation, increasing T-cell exhaustion, and promoting lung metastasis through the modulation of T-cell costimulatory and immune checkpoint molecules (ICOS, ICOSL, CD28, CTLA-4, and PD-L1)51. Here, CHI3L1 is linked to lung cancer.